| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 113.21B | 121.00B | 106.12B | 158.81B | 318.98B | 277.07B |
| Gross Profit | 113.21B | 121.00B | 123.32B | 104.86B | 316.11B | 271.14B |
| EBITDA | 18.59B | 26.91B | 19.85B | 12.65B | 16.45B | 17.50B |
| Net Income | 9.17B | 8.43B | 5.37B | 4.30B | 7.51B | 6.55B |
Balance Sheet | ||||||
| Total Assets | 1.87T | 1.73T | 1.51T | 1.41T | 1.38T | 1.17T |
| Cash, Cash Equivalents and Short-Term Investments | 0.00 | 44.39B | 42.55B | 308.46B | 293.80B | 266.36B |
| Total Debt | 33.28B | 82.12B | 101.43B | 117.05B | 95.17B | 61.27B |
| Total Liabilities | 1.74T | 1.61T | 1.38T | 1.31T | 1.27T | 1.05T |
| Stockholders Equity | 90.23B | 87.07B | 78.99B | 75.51B | 88.07B | 90.65B |
Cash Flow | ||||||
| Free Cash Flow | 97.21B | 116.24B | 127.67B | 88.72B | 94.48B | 110.33B |
| Operating Cash Flow | 106.92B | 125.95B | 134.60B | 95.02B | 98.63B | 114.20B |
| Investing Cash Flow | -158.04B | -95.63B | -130.95B | -80.30B | -99.62B | -110.85B |
| Financing Cash Flow | 9.76B | -27.91B | 19.79B | -9.76B | 9.06B | -945.65M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
83 Outperform | HK$202.54B | 4.72 | 34.37% | 5.94% | 49.90% | 203.77% | |
83 Outperform | $1.17T | 5.89 | 28.10% | 3.55% | 17.69% | 126.41% | |
76 Outperform | $352.34B | 5.36 | 18.41% | 3.54% | 15.08% | 23.13% | |
72 Outperform | $1.10T | 6.75 | 14.53% | 4.68% | 10.20% | 19.74% | |
72 Outperform | $862.52B | 18.85 | 15.16% | 2.21% | 5.65% | 30.47% | |
71 Outperform | $65.16B | 7.97 | 10.74% | 1.73% | 23.64% | 36.32% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% |
China Taiping Insurance Holdings Co, through its non-wholly owned subsidiary TPL, has entered into agreements to transfer its minority equity interests in four subject companies, including CRCCI and CRCC Kunlun, to CRCC for a total cash consideration of RMB6.50 billion. This transaction marks a strategic move for TPL, as it divests its stakes in these companies, potentially impacting its investment portfolio and financial strategy. The agreements ensure that all profits and losses incurred by the subject companies between the signing and closing dates will be managed by CRCC, indicating a clear transfer of operational responsibilities.
The most recent analyst rating on (HK:0966) stock is a Buy with a HK$18.00 price target. To see the full list of analyst forecasts on China Taiping Insurance Holdings Co stock, see the HK:0966 Stock Forecast page.
China Taiping Insurance Holdings Co has announced the unaudited financial figures and solvency statement of its subsidiaries for the third quarter of 2025. The announcement highlights the financial performance of its subsidiaries, including Taiping Life Insurance, Taiping General Insurance, and Taiping Reinsurance, which are regulated by the National Financial Regulatory Administration. The financial report reveals a net profit of RMB 1,813,042,000 and significant cash flows from operating activities, indicating strong operational performance. The disclosure is part of regulatory requirements for insurance companies with issued capital supplementary bonds, providing stakeholders with insights into the company’s financial health and compliance.
The most recent analyst rating on (HK:0966) stock is a Buy with a HK$18.00 price target. To see the full list of analyst forecasts on China Taiping Insurance Holdings Co stock, see the HK:0966 Stock Forecast page.
China Taiping Insurance Holdings Co announced the release of its subsidiaries’ solvency report for the third quarter of 2025. The report highlights the financial health and regulatory compliance of its subsidiaries under the China Risk Oriented Solvency System Phase II. The figures, based on unaudited preliminary data, indicate a strong solvency position, with a comprehensive solvency ratio of 248% at the end of the quarter, reflecting the company’s robust capital management and financial stability.
The most recent analyst rating on (HK:0966) stock is a Buy with a HK$18.00 price target. To see the full list of analyst forecasts on China Taiping Insurance Holdings Co stock, see the HK:0966 Stock Forecast page.
China Taiping Insurance Holdings Co has announced the appointment of Ms. NA Yanfang as an executive director and a member of several key committees, effective September 25, 2025. This strategic move is expected to enhance the company’s governance and operational efficiency, potentially strengthening its position in the competitive insurance market.
The most recent analyst rating on (HK:0966) stock is a Sell with a HK$9.40 price target. To see the full list of analyst forecasts on China Taiping Insurance Holdings Co stock, see the HK:0966 Stock Forecast page.
China Taiping Insurance Holdings Co has announced the composition of its board of directors and their roles within the company. The board includes executive, non-executive, and independent non-executive directors, with specific members assigned to various committees such as Audit, Nomination and Remuneration, Risk Management, and Strategy and Investment. This announcement highlights the company’s governance structure, which is crucial for stakeholders to understand the leadership and decision-making processes within the organization.
The most recent analyst rating on (HK:0966) stock is a Sell with a HK$9.40 price target. To see the full list of analyst forecasts on China Taiping Insurance Holdings Co stock, see the HK:0966 Stock Forecast page.
China Taiping Insurance Holdings Co, a prominent player in the insurance sector, operates across life, property, and casualty insurance, as well as asset management, with a strong presence in Hong Kong, Macau, and Mainland China.
China Taiping Insurance Holdings reported a robust financial performance for the first half of 2025, with a 12.2% increase in profit attributable to owners, reaching HK$6.764 billion. The company saw significant growth across its life insurance, property and casualty, and reinsurance segments, driven by enhanced insurance service results and strategic initiatives. The company’s total equity and assets also saw substantial increases, reflecting strong investment activities and strategic capital management.
The most recent analyst rating on (HK:0966) stock is a Sell with a HK$11.80 price target. To see the full list of analyst forecasts on China Taiping Insurance Holdings Co stock, see the HK:0966 Stock Forecast page.